Sentosa SQ Thyroid Cancer Panel

Detect sequence variants in thyroid cancer samples

INTENDED USE

The Sentosa SQ Thyroid Cancer Panel is a Next-Generation Sequencing (NGS)-based test that simultaneously detects hot spot mutations in 10 genes from formalin-fixed paraffin-embedded (FFPE) samples for research use only. This panel is intended to be used on the Sentosa SX101 with the Sentosa SX FFPE II gDNA Kit in conjunction with the Sentosa ST401 and Sentosa SQ301 instruments.

For Research Use Only. Not for use in diagnostics procedures.

TARGET GENES

Target GenesNumber of AmpliconsNumber of Target MutationsAmplicon Locations in Exon(s)
BRAF 2 15 11, 15
CTNNB1 1 5 2
EGFR 4 10 18, 19, 20, 21
FGFR3 3 9 7, 9, 14
KRAS 3 22 2, 3, 4
NRAS 3 19 2, 3, 4
PTEN 3 3 5, 7
PIK3CA 2 14 11, 22
RET1 1 1 16
TP53 3 7 4, 6, 7
Total 25 105  

FEATURES AND BENEFITS

Provision of Reliable Results

  • Minimal sample input - 10μm section of FFPE tissue or 5 ng DNA per library
  • Automated and user-friendly data analysis and results reporting with Sentosa SQ Reporter

Providing Laboratory Efficiency

  • From clinical sample to result in 2 days
  • Detection of up to 5% variant frequency
  • Seamless sample traceability and network connectivity with Sentosa Link

WORKFLOW

SPECIFICATIONS

AttributeValue
Sample Input 10 μm section of FFPE tissue (on glass slide or scroll)
Target Amplicons 25 targets and 1 control
Target Mutations 105
Min. Coverage / Target Mutation > 1,000 x
Analytical Sensitivity ≥ 5 ng DNA input; 5% variant frequency for mutation detection

ORDERING INFORMATION

ProductPack SizeItem Number
Sentosa SQ 318 Chip Kit (8) RUO 8 runs 300301

For availability in your country, please contact your Vela Diagnostics sales representative. Availability is subject to country's regulatory approval.